Moderna’s revenues plummeted after sales of its COVID vaccine fell 91%
@WSJ2 years ago
Pfizer raised its revenue outlook for the year on higher-than-expected sales from its Covid-19 vaccine despite reporting a drop in third-quarter revenue on.wsj.com
@forbes.com3 years ago
Novavax Reports Enduring Covid Immune Response Six Months After Vaccination
@forbes.com3 years ago
This Vaccine Maker Can ‘Dominate’ The Covid Market For Years To Come, Wells Fargo Predicts
@forbes.com3 years ago
What To Expect From Walgreens’ Stock As It Reports Q4 Results?
@forbes.com4 years ago
Pfizer Expects $33.5 Billion In Vaccine Revenue In 2021
@forbes.com4 years ago
All Eyes On Covid-19 Vaccine Contribution As Pfizer Reports Its Q1
@forbes.com5 years ago
Airlines Are Starved For Revenue. The Coronavirus Spike Has Quenched Chances Of A Rebound.
@forbes.coma year ago
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand
@abcnews.go.com3 years ago
BioNTech reports strong first half, expects demand to grow
@abcnews.go.com3 years ago
AstraZeneca sees $4B in COVID vaccine sales as revenue soars
@forbes.com3 years ago
What Will We See From CVS Health Stock Post Q3 Results?
@qz.com4 years ago
Moderna is buying back $1 billion of its stock after another bumper quarter
@axios.com4 years ago
Pfizer says COVID vaccine generated $3.5 billion in revenue in Q1
@theconversation.com4 years ago
Over 700 health experts are calling for urgent action to expand global production of COVID vaccines
What To Expect From Walgreens Stock As It Reports Its Q2 Results?
@rt.com3 years ago
Pfizer forecasts record-breaking earnings
@forbes.com3 years ago
Is Pfizer Stock Set To See Higher Levels Post Q3 Results?
@forbes.com4 years ago
What To Expect From CVS Health Stock Post Q2 Results?
@abcnews.go.com4 years ago
Vaccine sales power Pfizer through first quarter
@dailywire.com4 years ago
Pfizer Set To Rake In $15 Billion From COVID-19 Vaccine Sales
@forbes.com2 years ago
Rite Aid Loss Hits $67 Million As Covid Shots And Testing Decline
@forbes.com3 years ago
Novavax’s Revenues Will Surge This Year. Is The Stock A Buy?
@WSJ3 years ago
Gilead's revenue fell in the fourth quarter, as sales of its Covid-19 treatment remdesivir waned amid greater vaccine availability and declining hospitalization numbers on.wsj.com
@forbes.com3 years ago
What To Expect From Merck’s Q3?
@theguardian.com4 years ago
AstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021
@nytimes.com4 years ago
Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine
@forbes.com4 years ago
MSG Entertainment Bogged Down By COVID; Vaccine News To Boost Sentiments
